NanoString Technologies has named Alessandra Cesano its chief medical officer. Cesano brings more than 25 years of experience in drug development, diagnostics, and cancer immunology.
Cesano comes to NanoString from Cleave Biosciences where she served as CMO. She was also CMO and chief operations officer at Nodality. Prior to Nodality, she held various management positions at Biogen Idec, Amgen, and SmithKline Beecham Pharmaceuticals, and positions in academia and tumor immunology research.